Institute for Community Health

Greentown Labs in Somerville, MA is the largest climatetech accelerator in the world, serving as a launchpad for energy and climate startups driving the clean energy transition. As a world-class incubator, Greentown provides early-stage companies with lab space, coworking areas, machine shops, electronics labs, and business resources—all under one roof. Located just outside Boston, Greentown connects climatetech entrepreneurs with a powerful network of corporate partners, investors, and ecosystem leaders to help scale breakthrough technologies that address the climate crisis.

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.